Vocabria (cabotegravir) vs Pifeltro (doravirine)
Vocabria (cabotegravir) vs Pifeltro (doravirine)
Vocabria (cabotegravir) is an integrase inhibitor used in combination with other medications for the treatment of HIV-1 in adults, and it is available as an oral tablet and an injectable form that can be administered monthly or every two months. Pifeltro (doravirine) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) also used to treat HIV-1 in adults, but it is typically taken orally once daily in combination with other antiretroviral drugs. The choice between Vocabria and Pifeltro would depend on various factors, including the patient's treatment history, the presence of any drug-resistant HIV strains, potential drug interactions, and the preference for the frequency and mode of administration.
Difference between Vocabria and Pifeltro
Metric | Vocabria (cabotegravir) | Pifeltro (doravirine) |
---|---|---|
Generic name | Cabotegravir | Doravirine |
Indications | HIV-1 pre-exposure prophylaxis (PrEP) in combination with rilpivirine | Treatment of HIV-1 infection in combination with other antiretroviral agents |
Mechanism of action | Integrase strand transfer inhibitor (INSTI) | Non-nucleoside reverse transcriptase inhibitor (NNRTI) |
Brand names | Vocabria | Pifeltro |
Administrative route | Oral, intramuscular injection | Oral |
Side effects | Fever, fatigue, headache, musculoskeletal pain, sleep disorders, rash | Nausea, dizziness, headache, fatigue, diarrhea, abdominal pain, abnormal dreams |
Contraindications | Hypersensitivity to cabotegravir or any excipient | Hypersensitivity to doravirine or any component of the formulation |
Drug class | Integrase inhibitor | Non-nucleoside reverse transcriptase inhibitor |
Manufacturer | ViiV Healthcare | Merck Sharp & Dohme Corp. |
Efficacy
Efficacy of Vocabria (Cabotegravir) for HIV/AIDS
Vocabria, containing the active ingredient cabotegravir, is an antiretroviral medication used in the treatment and prevention of the human immunodeficiency virus (HIV). As an integrase strand transfer inhibitor (INSTI), cabotegravir works by blocking the virus's integrase enzyme, which is necessary for the HIV replication cycle. The efficacy of Vocabria for HIV treatment is often evaluated in combination with other antiretroviral drugs. Clinical trials have demonstrated that cabotegravir, when used in combination with other medications, can effectively reduce the viral load in individuals with HIV to undetectable levels, thereby improving immune function and reducing the risk of HIV-related complications.
Additionally, cabotegravir has been studied for its use as a long-acting pre-exposure prophylaxis (PrEP) to prevent HIV infection in at-risk populations. Studies have shown that long-acting injectable cabotegravir is highly effective in preventing the acquisition of HIV when administered every two months. This offers an alternative to daily oral PrEP regimens, potentially improving adherence and providing more options for individuals seeking preventive measures against HIV.
Efficacy of Pifeltro (Doravirine) for HIV/AIDS
Pifeltro, which contains the active substance doravirine, is another antiretroviral medication used in the treatment of HIV infection. Doravirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that prevents HIV from replicating by binding to and inhibiting the reverse transcriptase enzyme. The efficacy of Pifeltro in treating HIV has been demonstrated in clinical trials where it was used as part of combination therapy. Studies have shown that Pifeltro, when combined with other antiretroviral agents, is effective in reducing viral load to undetectable levels and improving CD4+ cell counts in many patients, which are critical markers of immune system health in people living with HIV.
The approval of Pifeltro for the treatment of HIV was based on the outcomes of pivotal trials that assessed its efficacy and safety in a diverse group of HIV-infected individuals, including those who were treatment-naive. Doravirine has been noted for its efficacy in suppressing viral replication, as well as for its favorable safety profile and lower potential for drug-drug interactions compared to some other NNRTIs. This makes Pifeltro a valuable option in the array of medications available for the management of HIV/AIDS.
Regulatory Agency Approvals
Vocabria
Pifeltro
Access Vocabria or Pifeltro today
If Vocabria or Pifeltro are not approved or available in your country (e.g. due to supply issues), you can access them via Everyone.org.
How it works
Make an enquiry
Choose the medicine you want to buy, answer a couple of questions, and upload your prescription to speed things up. We’ll get back to you within 24 hours.
Make an enquiry
Choose the medicine you want to buy, answer a couple of questions, and upload your prescription to speed things up. We’ll get back to you within 24 hours.
Breeze through the paperwork
We'll guide you through the required documents for importing unapproved medicine, ensuring you have all the necessary information.
Get a personalized quote
We’ll prepare a quote for you, including medicine costs and any shipping, administrative, or import fees that may apply.
Receive your medicine
Accept the quote and we’ll handle the rest - sourcing and safely delivering your medicine.
Some text on this page has been automatically generated. Speak to your physician before you start a new treatment or medication.
Let's talk
If you have any questions, call us or send us a message through WhatsApp or email:
Contact us